Retatrutide
Novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously
Under no circumstances should any products be used without the express direction of a licensed physician.
Full Description
Retatrutide is a novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. Research indicates it plays a significant role in metabolic regulation, glucose homeostasis, and energy expenditure pathways. Studies have explored its potential applications in metabolic research models, with the triple-agonist mechanism offering a unique approach compared to single or dual-agonist compounds.
Lab Result: Retatrutide
Batch Information
Available upon request
Purity
99.4%
CAS Number
2381089-83-2
Molecular Formula
C247H389N65O68
Molecular Weight
5425.2 g/mol
Storage
Store lyophilized at -20°C. Reconstituted at 2-8°C for up to 1 week. For long term storage, store at -20°C.
Solubility
Soluble in sterile water